Ginkgo Bioworks Holdings Statistics

Total Valuation

BMV:DNA has a market cap or net worth of MXN 6.76 billion. The enterprise value is 7.06 billion.

Market Cap	6.76B
Enterprise Value	7.06B

Important Dates

The last earnings date was Wednesday, February 25, 2026.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	45.32M
Shares Outstanding	n/a
Shares Change (YoY)	+6.87%
Shares Change (QoQ)	+2.60%
Owned by Insiders (%)	16.56%
Owned by Institutions (%)	56.70%
Float	41.66M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.21
PB Ratio	0.74
P/TBV Ratio	0.83
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.25
EV / Sales	2.41
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.19

Financial Position

The company has a current ratio of 4.92, with a Debt / Equity ratio of 0.86.

Current Ratio	4.92
Quick Ratio	4.66
Debt / Equity	0.86
Debt / EBITDA	n/a
Debt / FCF	-2.46
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -51.08% and return on invested capital (ROIC) is -18.06%.

Return on Equity (ROE)	-51.08%
Return on Assets (ROA)	-15.42%
Return on Invested Capital (ROIC)	-18.06%
Return on Capital Employed (ROCE)	-30.10%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	3.67M
Profits Per Employee	-6.75M
Employee Count	834
Asset Turnover	0.14
Inventory Turnover	n/a

Taxes

Income Tax	-15.07M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.40% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+7.40%
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	29.87
Average Volume (20 Days)	317

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.91

Income Statement

In the last 12 months, BMV:DNA had revenue of MXN 3.06 billion and -5.63 billion in losses. Loss per share was -101.53.

Revenue	3.06B
Gross Profit	2.22B
Operating Income	-5.55B
Pretax Income	-5.65B
Net Income	-5.63B
EBITDA	-4.82B
EBIT	-5.55B
Loss Per Share	-101.53

Full Income Statement

Balance Sheet

The company has 7.61 billion in cash and 7.92 billion in debt, giving a net cash position of -310.83 million.

Cash & Cash Equivalents	7.61B
Total Debt	7.92B
Net Cash	-310.83M
Net Cash Per Share	n/a
Equity (Book Value)	9.16B
Book Value Per Share	157.30
Working Capital	6.77B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.08 billion and capital expenditures -137.99 million, giving a free cash flow of -3.22 billion.

Operating Cash Flow	-3.08B
Capital Expenditures	-137.99M
Free Cash Flow	-3.22B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 72.39%, with operating and profit margins of -181.08% and -183.81%.

Gross Margin	72.39%
Operating Margin	-181.08%
Pretax Margin	-184.30%
Profit Margin	-183.81%
EBITDA Margin	-157.40%
EBIT Margin	-181.08%
FCF Margin	n/a

Dividends & Yields

BMV:DNA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.87%
Shareholder Yield	-6.87%
Earnings Yield	-83.30%
FCF Yield	-47.60%

Stock Splits

The last stock split was on August 20, 2024. It was a reverse split with a ratio of 0.025.

Last Split Date	Aug 20, 2024
Split Type	Reverse
Split Ratio	0.025

Scores

BMV:DNA has an Altman Z-Score of -7.48 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.48
Piotroski F-Score	1